News

InSphero Launches 14 Day Hepatotoxicity Testing Service Schlieren, Switzerland, Oct 13, 2015 – Monthly contract screening service simplifies long-term, repeat-dose testing of drugs in 3D

InSphero Granted Hanging Drop Patent in United States Schlieren, Switzerland, September 29, 2015 – Patent establishes protection of InSphero GravityPLUSTM technology in all major global markets, key

InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms Schlieren, Switzerland, August 5, 2015 – PerkinElmer was named as exclusive distributor of InSphero

InSphero AG Secures CHF 20 Million Series C Financing Schlieren, Switzerland, July 8, 2015 – Leading 3D cell culture company gains new long-term investor to

InSphero Launches Enhanced Ultra-low Attachment Plate for Scaffold-free 3D Cell Culture Schlieren, Switzerland, May 7, 2015 – GravityTRAP™ ULA Plate design simplifies medium exchange and

InSphero Publication Honored for Potential to Reduce Use of Research Animals Schlieren, Switzerland, March 17, 2015 – Nature Communications paper co-authored with ETH Zurich wins “highly

Proteomic Profiling of 3D Liver Microtissues Provides New Insight Into Acetaminophen Toxicity Schlieren-Zurich, Switzerland, March 10, 2015 – InSphero, Biognosys paper reveals relevant proteomic changes

3D Liver Spheroid Model in Use by MIP-DILI, IMI’s Drug Liver Injury Project Schlieren, Switzerland, January 21, 2015 – European consortium will use 3D liver

Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress Schlieren, Switzerland, December 11, 2014 – Data from a comparative 3D versus 2D

Protea Biosciences releases mass spectrometry imaging data for characterizing 3D microtissues Schlieren, Switzerland and Morgantown, West Virginia, November 5, 2014 – Mass Spectrometry Imaging Data presented at

InSphero Wins ACES Award Schlieren, Switzerland, October 14, 2014 – Second honor in three weeks, this time with an ACES Award, continues momentum for leading

Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues. Schlieren, Switzerland and Morgantown, West Virginia, October 2, 2014 – Protea to